USE OF HYPOXIA INDUCIBLE FACTOR 2ALPHA FOR CURING NEONATAL RESPIRATORY DISTRESS SYNDROME AND AS A TARGET FOR THE TREATMENT OF PULMONARY HYPERTENSION

摘要

The current invention relates to the field of hypoxia-induced disorders andmore specifically to the use of hypoxia inducible factor 2a.alpha. as a targetin a method for the screening for molecules that can be used for the treatmentof pulmonary hypertension. The invention further relates to the use of HIF-2.alpha. and/or of the HIF-2a.alpha. inducible protein VEGF for the treatmentof neonatal respiratory distress syndrome.